Related Experiment Video
Updated: Aug 18, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
Reversal of oliguric tacrolimus nephrotoxicity in children
Gwenn E McLaughlin1, Carolyn L Abitbol
1Department of Pediatrics, University of Miami School of Medicine/Holtz Children's Hospital, Miami, FL 33130, USA. gmclaugh@med.miami.edu
Background:
Acute tacrolimus toxicity is manifest by oliguria and elevated serum creatinine. Various vasoregulatory molecules have been implicated in calcineurin inhibitor-mediated nephrotoxicity, including calcium, adenosine and endothelin. Theophylline (THEO), a non-specific adenosine-receptor antagonist prevents renal dysfunction from various nephrotoxins which mediate vasoconstriction. In the setting of acute tacrolimus toxicity, we demonstrated that administration of THEO along with a loop diuretic (LD) enhanced diuresis. This randomized, controlled trial was undertaken to confirm these earlier findings under more rigorous conditions.
Methods:
Children with non-renal visceral transplant(s) and evidence of tacrolimus nephrotoxicity oliguria with a 25% increase in serum creatinine concentration from baseline, a whole blood tacrolimus concentration >20 ng/dl and oliguria resistant to therapy with a LD were randomized to receive either THEO (n = 10) or normal saline placebo (n = 8). Using pre and post (6 h) timed urine collections and coincident plasma concentrations the following were measured or calculated: urine flow rate, net fluid balance, creatinine clearance, fractional excretion of chloride, free water clearance and distal delivery of chloride.
Results:
These patients had markedly impaired creatinine clearance at the onset of tacrolimus toxicity. Urine flow increased in the LD + THEO group by 110% over baseline, but was unchanged in the LD + NS group. An increase in creatinine clearance did not reach statistical significance (P = 0.09). Fractional excretion of chloride and distal solute delivery increased after THEO treatment.
Conclusions:
THEO induced a solute diuresis during furosemide-resistant oliguric tacrolimus toxicity in paediatric patients with a trend towards improved renal function.
Insights
Theophylline (THEO) combined with a loop diuretic (LD) increased urine flow in children with tacrolimus toxicity. This treatment enhanced diuresis and showed a trend towards improved kidney function in patients resistant to standard diuretic therapy.
Area of Science:
- Pediatric Nephrology
- Pharmacology
- Transplant Medicine
Background:
- Tacrolimus (TAC) is a calcineurin inhibitor used in transplantation, but it can cause nephrotoxicity, characterized by reduced urine output and elevated creatinine.
- Vasoregulatory mechanisms, including calcium, adenosine, and endothelin, are implicated in TAC-induced kidney damage.
- Theophylline (THEO), an adenosine-receptor antagonist, has shown potential in mitigating nephrotoxicity caused by vasoconstrictive agents.
Purpose of the Study:
- To confirm findings that theophylline (THEO) combined with a loop diuretic (LD) enhances diuresis in pediatric patients with acute tacrolimus toxicity.
- To rigorously evaluate the efficacy of THEO in improving renal function during furosemide-resistant oliguric tacrolimus nephrotoxicity.
Main Methods:
- A randomized, controlled trial involving pediatric patients with confirmed tacrolimus nephrotoxicity, oliguria, and resistance to loop diuretics.
- Patients were randomized to receive either theophylline (THEO) or normal saline (NS) placebo alongside a loop diuretic.
- Key parameters measured included urine flow rate, creatinine clearance, fractional chloride excretion, and distal solute delivery.
Main Results:
- The group receiving loop diuretic plus theophylline (LD + THEO) demonstrated a 110% increase in urine flow compared to baseline.
- The loop diuretic plus normal saline (LD + NS) group showed no significant change in urine flow.
- While not statistically significant (P = 0.09), creatinine clearance showed a trend toward improvement in the LD + THEO group. Fractional excretion of chloride and distal solute delivery increased post-THEO treatment.
Conclusions:
- Theophylline (THEO) effectively induced a solute diuresis in pediatric patients experiencing furosemide-resistant oliguric tacrolimus toxicity.
- The combination of theophylline and a loop diuretic shows promise in managing tacrolimus-induced nephrotoxicity and improving renal function in this patient population.
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Pharmacokinetics in Pediatric Patients: Drug Excretion
Kidney Transplant III: Nursing Management
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Drug Elimination by Renal Route: Tubular Reabsorption